fludarabine phosphate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
FLUDARABINE EBEWE fludarabine phosphate 50 mg / 2 mL concentrated injection vial AUST R: 135540Active ingredients:
fludarabine phosphate
Dosage form:
Injection, concentrated
Sponsor:
Sandoz Pty Ltd
Phone:
1800726369
|
From
19 Mar 2026
to
30 Apr 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An overseas-registered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group, can be contacted for details on supply on 1300 077 674.
|
FLUDARABINE JUNO fludarabine phosphate 50 mg powder for injection vial AUST R: 147831Active ingredients:
fludarabine phosphate
Dosage form:
Injection, powder for
Sponsor:
Juno Pharmaceuticals Pty Ltd
Phone:
0388881288
|
From
19 May 2025
to
31 Jul 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An alternative generic product is available. An overseas-registered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group, can be contacted for details on supply on 1300 077 674.
|